TIMP1 and prostate carcinoma: To determine the potential role of TIMP-1 in prostate cancer progression, we selected three prostate cancer cells, PC3, 22RV1, and LAPC-4, because they are capable of forming tumors in immunocompromised mice, to overexpress v5-epitope tagged exogenous TIMP-1 (Figure 2A).